Success Stories
Highlights of the PCI news focused on Penn commercialization accomplishments
Highlights of the PCI news focused on Penn commercialization accomplishments
Awarded a patent that describes novel autophagy inhibitors potentially useful in cancer therapy.
Awarded a patent that describes mRNA trans-splicing as a gene therapy for treatment of ocular diseases caused by defects in large genes.
Arjun Raj, PhD, Assistant Professor in the School of Engineering, was awarded a patent for technology that captures an innovative method to detect Single Nucelotide Polymorphisms (SNPs).
The Daily podcast by the New York Times interviewed Dr. Katalin Kariko about the long road to getting mRNA into the vaccines that are winning the war against COVID.
The 2020-21 year has been unique and challenging, yet successful. The University community of students, faculty, and staff overcame significant obstacles to flourish.
A two-year-old Philadelphia gene therapy company spun out of the University of Pennsylvania has raised $76 million
A low-cost, rapid diagnostic test for COVID-19 developed by Penn Medicine provides COVID-19 results within four minutes with 90% accuracy.
On May 6th, as part of the Cellicon Valley '21 two-day event, John Swartley, Managing Director of PCI, joined Penn Medicine faculty to discuss the commercialization of CAR-T technology
As part of Philly Tech Week 2021 and the Technical.ly Philly Introduced Conference, PCI and the Pennovation Center, hosted an educational webinar on the range of innovations emerging from Penn in the